European Collaboration in Health Technology Assessment (HTA): goals, methods and outcomes with specific focus on medical devices-Reference-Cited by-同舟云学术

European Collaboration in Health Technology Assessment (HTA): goals, methods and outcomes with specific focus on medical devices

Published:2019-02-06 Issue:11-12 Volume:169 Page:284-292
ISSN:0043-5341
Container-title:Wiener Medizinische Wochenschrift
language:en
Short-container-title:Wien Med Wochenschr

Author:

Erdös Judit,Ettinger Sabine,Mayer-Ferbas Julia,de Villiers Cecilia,Wild Claudia

Funder

Third Health Programme

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10354-019-0684-0.pdf

Reference29 articles.

1. CRD/Centre for Reviews and Dissemination. CRD-Databases: DARE, NHS EED, HTA. University of York, York. Available from: http://www.crd.york.ac.uk/CRDWeb/ . 2019.

2. Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare. 2011.

3. Technical Annex1b EUnetHTA JA2 Grant Agreement. 2012.

4. Kristensen FB, Makela M, Neikter SA, Rehnqvist N, Haheim LL, Mørland B, et al. European network for Health Technology Assessment, EUnetHTA: planning, development, and implementation of a sustainable European network for Health Technology Assessment. Int J Technol Assess Health Care. 2009;25(Supplement 2):107–16.

5. EUnetHTA Work Package 7. Consolidated procedures for Early Dialogues (Drug and Non-drug). 2015.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Domains and Methods of Medical Device Technology Evaluation: A Systematic Review;Public Health Reviews;2024-07-24

2. Health Technology Assessment: Current State of Access to Medical Device Outcomes;IFMBE Proceedings;2024

3. EUnetHTA relative effectiveness assessments: efforts to increase usability, transparency and inclusiveness;International Journal of Technology Assessment in Health Care;2022

4. A Review of the Evidence on Attitudes, Perceived Impacts and Motivational Factors for European Member State Collaboration for Pricing and Reimbursement of Medicines: Time for the EEA Member States to Apply Their Experience and Expertise in Evidence-Based Decision Making to Their Current Pharmaceutical Policy Challenges;Frontiers in Pharmacology;2021-11-12

5. Regulatory and HTA early dialogues in medical devices;Health Policy;2021-10